SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-18-010663
Filing Date
2018-07-30
Accepted
2018-07-30 17:03:34
Documents
13
Period of Report
2018-07-30

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 18376
2 ex99-1.htm EX-99.1 17331
3 image_001.jpg GRAPHIC 17376
4 ex99-2.htm EX-99.2 19093
5 ex99-3.htm EX-99.3 406774
6 img_2.jpg GRAPHIC 14270
7 img_3.jpg GRAPHIC 4400
8 img_4.jpg GRAPHIC 3620
9 img_5.jpg GRAPHIC 5995
10 img_6.jpg GRAPHIC 288198
11 img_7.jpg GRAPHIC 255141
12 img_8.jpg GRAPHIC 290968
13 img_9.jpg GRAPHIC 256792
  Complete submission text file 0001493152-18-010663.txt   2029141
Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377
Business Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 011 49 214 876 00
Biofrontera AG (Filer) CIK: 0001712641 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38396 | Film No.: 18978346
SIC: 2834 Pharmaceutical Preparations